Estrogen-related receptor alpha induces the expression of vascular endothelial growth factor in breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 114, Issue 1-2, 2009, Pages 106-112

  Stein, Rebecca A ^a   Gaillard, Stéphanie ^b   McDonnell, Donald P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; ESRRA; Estrogen related receptor; Vascular endothelial growth factor, VEGF

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; DNA BINDING; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; PROTEIN FUNCTION; PROTEIN SECRETION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 62949222778     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.02.010     Document Type: Article

References (33)

1. Giguere V., Yang N., Segui P., and Evans R.M. Identification of a new class of steroid hormone receptors. Nature 331 (1988) 91-94
2. Suzuki T., Miki Y., Moriya T., Shimada N., Ishida T., Hirakawa H., Ohuchi N., and Sasano H. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. Cancer Res. 64 13 (2004) 4670-4676
3. Ariazi E.A., Clark G.M., and Mertz J.E. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res. 62 22 (2002) 6510-6518
4. Huss J.M., Torra I.P., Staels B., Giguere V., and Kelly D.P. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor at signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol. Cell. Biol. 24 20 (2004) 9079-9091
5. Gaillard S., Grasfeder L.L., Haeffele C.L., Lobenhofer E.K., Chu T.M., Wolfinger R., Kazmin D., Koves T.R., Muoio D.M., Chang C.Y., and McDonnell D.P. Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs. Mol. Cell 24 5 (2006) 797-803
6. Villena J.A., Hock M.B., Chang W.Y., Barcas J.E., Giguere V., and Kralli A. Orphan nuclear receptor estrogen-related receptor alpha is essential for adaptive thermogenesis. Proc. Natl. Acad. Sci. U.S.A. 104 4 (2007) 1418-1423
7. Vega R.B., and Kelly D.P. A role for estrogen-related receptor alpha in the control of mitochondrial fatty acid beta-oxidation during brown adipocyte differentiation. J. Biol. Chem. 272 50 (1997) 31693-31699
8. Ao A., Wang H., Kamarajugadda S., and Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc. Natl. Acad. Sci. U.S.A. (2008)
9. R. Stein, C.Y. Chang, D. Kazmin, J. Way, T. Schroeder, M. Wergin, M. Dewhirst, D.P. McDonnell, Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer, Cancer Res., in press.
10. Huss J.M., Imahashi K., Dufour C.R., Weinheimer C.J., Courtois M., Kovacs A., Giguere V., Murphy E., and Kelly D.P. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab. 6 1 (2007) 25-37
11. Zuercher W.J., Gaillard S., Orband-Miller L.A., Chao E.Y.H., Shearer B.G., Jones D.G., Miller A.B., Collins J.L., McDonnell D.P., and Willson T.M. Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgamma. J. Med. Chem. 48 (2005) 3107-3109
12. Chang C.Y., Norris J.D., Gron H., Paige L.A., Hamilton P.T., Kenan D.J., Fowlkes D., and McDonnell D.P. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta. Mol. Cell. Biol. 19 12 (1999) 8226-8239
13. Wu J., Brandt S., and Hyder S.M. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells. Mol. Endocrinol. 19 2 (2005) 312-326
14. Gaillard S., Dwyer M.A., and McDonnell D.P. Definition of the molecular basis for estrogen receptor-related receptor-alpha-cofactor interactions. Mol. Endocrinol. 21 1 (2007) 62-76
15. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., and Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERR alpha). J. Biol. Chem. 278 11 (2003) 9013-9018
16. Baines A.T., Lim K.H., Shields J.M., Lambert J.M., Counter C.M., Der C.J., and Cox A.D. Use of retrovirus expression of interfering RNA to determine the contribution of activated k-ras and ras effector expression to human tumor cell growth. Methods Enzymol. 407 (2005) 556-574
17. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 4 (2001) 402-408
18. Norris J., Fan D., Aleman C., Marks J.R., Futreal P.A., Wiseman R.W., Iglehart J.D., Deininger P.L., and McDonnell D.P. Identification of a new subclass of alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J. Biol. Chem. 270 (1995) 22777-22782
19. Ben-Shoshan M., Amir S., Dang D.T., Dang L.H., Weisman Y., and Mabjeesh N.J. 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol. Cancer Ther. 6 4 (2007) 1433-1439
20. Arany Z., Foo S.Y., Ma Y., Ruas J.L., Bommi-Reddy A., Girnun G., Cooper M., Laznik D., Chinsomboon J., Rangwala S.M., Baek K.H., Rosenzweig A., and Spiegelman B.M. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451 7181 (2008) 1008-1012
21. Stoner M., Wormke M., Saville B., Samudio I., Qin C., Abdelrahim M., and Safe S. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene 23 5 (2004) 1052-1063
22. A. Castet, A. Herledan, S. Bonnet, S. Jalaguier, J.-M. Vanacker, V. Cavailles, RIP140 differentially regulates estrogen receptor-related receptor transactivation depending on target genes, Mol. Endocrinol., in press.
23. Sumi D., and Ignarro L.J. Sp1 transcription factor expression is regulated by estrogen-related receptor alpha1. Biochem. Biophys. Res. Commun. 328 1 (2005) 165-172
24. Sumi D., and Ignarro L.J. Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression. Proc. Natl. Acad. Sci. U.S.A. 100 24 (2003) 14451-14456
25. Miralem T., Steinberg R., Price D., and Avraham H. VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells. Oncogene 20 39 (2001) 5511-5524
26. Price D.J., Miralem T., Jiang S., Steinberg R., and Avraham H. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ. 12 3 (2001) 129-135
27. Li C.Y., Shan S., Huang Q., Braun R.D., Lanzen J., Hu K., Lin P., and Dewhirst M.W. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J. Natl. Cancer Inst. 92 2 (2000) 143-147
28. Liang Y., Brekken R.A., and Hyder S.M. Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones. Endocr. Relat. Cancer 13 3 (2006) 905-919
29. Baek J.H., Jang J.E., Kang C.M., Chung H.Y., Kim N.D., and Kim K.W. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19 40 (2000) 4621-4631
30. Guo P., Fang Q., Tao H.Q., Schafer C.A., Fenton B.M., Ding I., Hu B., and Cheng S.Y. Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo. Cancer Res. 63 15 (2003) 4684-4691
31. Hyder S.M., Stancel G.M., Chiappetta C., Murthy L., Boettger-Tong H.L., and Makela S. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res. 56 17 (1996) 3954-3960
32. Garvin S., Nilsson U.W., and Dabrosin C. Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells. Br. J. Cancer 93 9 (2005) 1005-1010
33. Dabrosin C., Margetts P.J., and Gauldie J. Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer. Int. J. Cancer 107 4 (2003) 535-540